Global Erythropoietin Market Growth 2023-2029

Global Erythropoietin Market Growth 2023-2029

Product Code:457870

Published Date: Feb 08,2023

Pages: 92

Region: Global

Category: Pharma & Healthcare

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

SELECT A FORMAT

ADD TO BASKET

BUY NOW

Provide comprehensive and accurate analysis and reports according to your exact requirements

Provide comprehensive and accurate analysis and reports according to your exact requirements

CONTACT US

Erythropoietin is produced by interstitial fibroblasts in the kidney in close association with peritubular capillary and proximal convoluted tubule. It is also produced in perisinusoidal cells in the liver. While liver production predominates in the fetal and perinatal period, renal production is predominant during adulthood. 
Erythropoietin is an essential hormone for red blood cell production. Without it, definitive erythropoiesis does not take place. Under hypoxic conditions, the kidney will produce and secrete erythropoietin to increase the production of red blood cells by targeting CFU-E, proerythroblast and basophilic erythroblast subsets in the differentiation. Erythropoietin has its primary effect on red blood cell progenitors and precursors (which are found in the bone marrow in humans) by promoting their survival through protecting these cells from apoptosis, or cell death.

In this report, we definite one unit for 1ml, except Epoetin-alfa type, which one unit means 10000units/ml
LPI (LP Information)' newest research report, the “Erythropoietin Industry Forecast” looks at past sales and reviews total world Erythropoietin sales in 2022, providing a comprehensive analysis by region and market sector of projected Erythropoietin sales for 2023 through 2029. With Erythropoietin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Erythropoietin industry.

This Insight Report provides a comprehensive analysis of the global Erythropoietin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Erythropoietin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Erythropoietin market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Erythropoietin and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Erythropoietin.

The global Erythropoietin market size is projected to grow from US$ 8958.6 million in 2022 to US$ 13490 million in 2029; it is expected to grow at a CAGR of 13490 from 2023 to 2029.

The major players in global Erythropoietin market include Amgen, Johnson & Johnson, etc. The top 2 players occupy about 60% shares of the global market. North America is the main market, and occupies over 65% of the global market. Epoetin-alfa is the main type, with a share about 80%. Kidney Disorders is the key application, which holds a share over 40%.

This report presents a comprehensive overview, market shares, and growth opportunities of Erythropoietin market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:
Segmentation by type
    Epoetin-alfa
    Epoetin-beta
    Darbepoetin-alfa
    Others

Segmentation by application
    Anemia
    Kidney Disorders
    Others

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
    Amgen
    Johnson & Johnson
    Roche
    Galenica
    Emcure
    Kyowa Hakko Kirin
    3SBio
    Biocon
    LG Life Sciences

Key Questions Addressed in this Report
What is the 10-year outlook for the global Erythropoietin market?
What factors are driving Erythropoietin market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Erythropoietin market opportunities vary by end market size?
How does Erythropoietin break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?